Radient Pharmaceuticals Informed by AMEX of Possible DelistingPress Release Source: Radient Pharmaceuticals Corporation On Monday December 28, 2009, 5:37 pm EST
TUSTIN, CA--(Marketwire - 12/28/09) - Radient Pharmaceuticals Corporation (RPC) (AMEX:RPC - News) today announced it has received notice from the NYSE Amex that the Company is not in compliance with the continued listing standard in Section 1003(a)(iv) of the Exchange's Company Guide. The Company has until January 22, 2010 to submit a plan to regain compliance by June 23, 2010. If the Company does not submit a plan or if the plan is not accepted by the Exchange, or if our plan is accepted but we fail to make progress consistent with our plan, or we are not in compliance by June 23, 2010, the Company would be subject to delisting procedures.
For additional information on Radient Pharmaceuticals, ADI and its portfolio of products visit the Company's corporate website at www.Radient-Pharma.com
. For Investor Relations information contact Kristine Szarkowitz at kszarkowitz@Radient-Pharma.com